Juan Revilla-Garcia
Sevilla, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Galectin-3 shapes microglial phenotype through endogenous and exogenous mechanisms.
Journal: Frontiers in cellular neuroscience
Published: October 21, 2025
Galectin 3: A new player in the pathogenesis of Parkinson's disease.
Journal: Neural regeneration research
Published: November 13, 2024
The role of microglia in the prion-like transmission of protein aggregates in neurodegeneration.
Journal: Brain communications
Published: April 29, 2024
Dopaminergic neurons lacking Caspase-3 avoid apoptosis but undergo necrosis after MPTP treatment inducing a Galectin-3-dependent selective microglial phagocytic response.
Journal: Cell death & disease
Published: July 26, 2023
Inflammatory bowel disease induces pathological α-synuclein aggregation in the human gut and brain.
Journal: Neuropathology and applied neurobiology
Published: May 22, 2023
Correction to: Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease.
Journal: Acta neuropathologica
Published: February 15, 2023
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson's disease.
Journal: Acta neuropathologica
Published: November 24, 2022
Inflammatory Animal Models of Parkinson's Disease.
Journal: Journal of Parkinson's disease
Published: June 06, 2022
APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases.
Journal: Molecular neurodegeneration
Published: January 31, 2022
The Absence of Caspase-8 in the Dopaminergic System Leads to Mild Autism-like Behavior.
Journal: Frontiers in cell and developmental biology
Published: December 20, 2021
Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration.
Journal: Cell death & disease
Published: December 01, 2021
Galectin-3 Deletion Reduces LPS and Acute Colitis-Induced Pro-Inflammatory Microglial Activation in the Ventral Mesencephalon.
Journal: Frontiers in pharmacology
Published: May 07, 2021
Last Updated: 09/26/2026